The Medical Research Council has given the University of Nottingham £600,000 to give research into medical disease a step forward.
Researchers at the University of Nottingham have just been awarded a £600,000 medical grant.
Received from the Medical Research Council, the prestigious Confidence in Concept award will allow the university to embark on new drug developments and diagnostic technologies.
Over a 12 month period the projects will fall into three categories. Biomedical markers and diagnostics, biomedical imaging, and drug discovery, development and delivery.
It is hoped that these broad groups will be used to bring developments out of the lab and convert them into real advances in patient care.
Professor Saul Tendler, Pro-Vice-Chancellor for Research, said: “We are delighted to have been recognised again by the MRC in these awards.
“This grant will fund projects developing interventions which would represent a step change improvement in the treatment and diagnosis of serious disease.”
The university previously received this grant in 2012, the £600,000 and past £400,000 combined, leaves the team with a total of £1 million to encourage more developments.
With the additional support from the MRC, research will be able to take a step further. Funding will help new treatments get on the market for patients.
The concept is usually hard to justify to outer bodies.
Professor Saul Tendler says: “The Confidence in Concept award is particularly aimed at research which has the potential to have a huge impact on patient care but which may struggle to cross the so-called ‘valley of death’.
“The funding divide between the initial breakthrough stage and clinical trial can often be a significant financial barrier when bringing new treatments and technologies to the market.”
Research undertaken at the university is recognised globally, and already the first set of money from the Confidence in Concept scheme has gone onto support trials in finding a more reliable MRI test for multiple sclerosis across all scanners.
Additionally there have been improvements for gastric conditions such as dyspepsia, reflux disease and diabetic gastro paresis.
According to the Research Assessment Exercise the work of the researchers at the University of Nottingham is of international quality and is reflected in their new tests to detect Parkinson’s disease in its earliest stages.
Later this year, further to the Universities grant, they will again be able to apply for more funding that will be available to them later this year.
Both the Pro-Vice-Chancellor for research, Saul Tendler, and his research team are likely to announce their successful projects in the spring this year.